Targeted drug delivery to the peripheral nervous system using gene therapy

► HSV-based vectors are particularly suitable for delivering genes to the DRG. ► Preclinical studies in pain and for treatment of polyneuropathy are reviewed. ► Results of the first phase 1 clinical trial support this approach.